SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-21-003032
Filing Date
2021-06-16
Accepted
2021-06-16 16:05:18
Documents
2
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 form3-06162021_040601.html 3  
1 form3-06162021_040601.xml 3 1676
2 ex24-06162021_040601.htm EX-24 6473
  Complete submission text file 0001415889-21-003032.txt   9530
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SIGILON THERAPEUTICS, INC. 100 BINNEY STREET, SUITE 600 CAMBRIDGE MA 02142
Business Address
Story Brooke (Reporting) CIK: 0001866136 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39746 | Film No.: 211021507